Everand Logo

Welcome to Everand!

  • Los Angeles Times

    One of the most promising drugs for Alzheimer's disease fails in clinical trials

    by Melissa Healy, Los Angeles Times Jan 10, 2018 3 minutes

    To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

    An experimental drug called idalopirdine failed to help people with mild to moderate Alzheimer's disease in a trio of trials that involved 2,525 patients in 34 countries. Not only did the drug fail to bring about any meaningful change in cognitive tests that are widely used in diagnosing and tracking the progress

    You’re reading a preview, subscribe to read more.

    More from Los Angeles Times

    Los Angeles Times3 min read
    Dylan Hernández: James Harden Delivers A Trademark Disappearing Act At The Worst Time For The Clippers
    LOS ANGELES — James Harden produced one of his trademark playoff performances on Wednesday night. Actually, that's not true. This was worse. In the Clippers' 123-93 loss to the Dallas Mavericks in Game 5 of their first-round series, the longtime post
    Los Angeles Times2 min readCrime & Violence
    Editorial: The Attack On The UCLA Protest Encampment Was Unacceptable
    It is never OK to use physical violence against people with whom you disagree. This should be obvious, but the events that unfolded on the UCLA campus early Wednesday show the consequences when that message is lost. Late Tuesday night, a large group
    Los Angeles Times4 min readCrime & Violence
    Commentary: The Trump Prosecution Has A Michael Cohen Problem — And A Plan To Solve It
    Since the opening of the Donald Trump’s New York trial — when the former president’s counsel told the jury that the prosecution’s star witness “cannot be trusted” — the defense has telegraphed its principal strategy: Eviscerate Michael Cohen. As Trum

    Related Books & Audiobooks